Scribe Therapeutics Inc. (SCTX) vs Treace Medical Concepts, Inc. (TMCI)

A side-by-side comparison of Scribe Therapeutics Inc. and Treace Medical Concepts, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

SCTX

Scribe Therapeutics Inc.

$264M

$16.33HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

TMCI

Treace Medical Concepts, Inc.

$259M

$4.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — SCTX vs TMCI

growth of $100 · dividends reinvested · last 1y

SCTX +8.1% (+8.1%/yr)TMCI +12.8% (+12.8%/yr)TMCI compounded faster over this window

SCTX TMCI

Metrics side by side

Total return (annualized)

Metric	SCTX	TMCI
Total return (1Y)	N/A	-29.44%
Total return CAGR (3Y)	N/A	-28.56%
Total return CAGR (5Y)	N/A	-29.41%

SCTX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full SCTX analysis Full TMCI analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.